INFECTIOUS INNOVATION

We are translating the lessons learned from our successes combating HIV, HBV, and HCV to address viral diseases like Dengue Fever (A) and the threat it poses to places like South America (B), Central America, Southeast Asia, and Australia.
We are translating the lessons learned from our successes combating HIV, HBV, and HCV to address viral diseases like Respiratory Syncytial Virus (A), a major cause of morbidity and mortality in children in Europe (B) and the U.S.
We are translating the lessons learned from our successes combating HIV, HBV, and HCV to address viral diseases like SARS (A) that have emerged in places like China (B).

DRIVE’s Leadership has discovered and advanced the development of some of the world’s most successful and valuable antiviral drugs. DRIVE combines these seasoned leaders with over $20M in foundational funding from Emory University to build a world class infrastructure for developing drugs for viral diseases of global concern. We invite you to join with us in our urgent quest to develop valuable and critically needed drugs to fight against these viral threats.

Learn More

Team

DRIVE’s leadership team has extensive experience in the biotechnology and pharmaceutical industries with proven track records in discovering and advancing some of the world’s most successful and valuable antiviral drugs.

Read More

Collaborations

We are seeking strategic industry, academic, and government collaborators to provide exciting new discoveries, financing, and late stage commercial development in order to move more therapeutics from bench to patient.

Read More

News

DRIVE is off to a fast start. Track our progress.

Read More